Tags

Type your tag names separated by a space and hit enter

Analysis and advanced oxidation treatment of a persistent pharmaceutical compound in wastewater and wastewater sludge-carbamazepine.
Sci Total Environ. 2014 Feb 01; 470-471:58-75.ST

Abstract

Pharmaceutically active compounds (PhACs) are considered as emerging environmental problem due to their continuous input and persistence to the aquatic ecosystem even at low concentrations. Among them, carbamazepine (CBZ) has been detected at the highest frequency, which ends up in aquatic systems via wastewater treatment plants (WWTPs) among other sources. The identification and quantification of CBZ in wastewater (WW) and wastewater sludge (WWS) is of major interest to assess the toxicity of treated effluent discharged into the environment. Furthermore, WWS has been subjected for re-use either in agricultural application or for the production of value-added products through the route of bioconversion. However, this field application is disputable due to the presence of these organic compounds and in order to protect the ecosystem or end users, data concerning the concentration, fate, behavior as well as the perspective of simultaneous degradation of these compounds is urgently necessary. Many treatment technologies, including advanced oxidation processes (AOPs) have been developed in order to degrade CBZ in WW and WWS. AOPs are technologies based on the intermediacy of hydroxyl and other radicals to oxidize recalcitrant, toxic and non-biodegradable compounds to various by-products and eventually to inert end products. The purpose of this review is to provide information on persistent pharmaceutical compound, carbamazepine, its ecological effects and removal during various AOPs of WW and WWS. This review also reports the different analytical methods available for quantification of CBZ in different contaminated media including WW and WWS.

Authors+Show Affiliations

INRS-ETE, Université du Québec, 490, Rue de la Couronne, Québec G1K 9A9, Canada.INRS-ETE, Université du Québec, 490, Rue de la Couronne, Québec G1K 9A9, Canada. Electronic address: satinder.brar@ete.inrs.ca.INRS-ETE, Université du Québec, 490, Rue de la Couronne, Québec G1K 9A9, Canada.Phytronix Technologies, 4535 Boulevard Wilfrid Hamel, Québec G1P 2J7, Canada.US Environmental Protection Agency, P.O. Box 17-2141, Kansas City, KS 66117, USA.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

24140682

Citation

Mohapatra, D P., et al. "Analysis and Advanced Oxidation Treatment of a Persistent Pharmaceutical Compound in Wastewater and Wastewater Sludge-carbamazepine." The Science of the Total Environment, vol. 470-471, 2014, pp. 58-75.
Mohapatra DP, Brar SK, Tyagi RD, et al. Analysis and advanced oxidation treatment of a persistent pharmaceutical compound in wastewater and wastewater sludge-carbamazepine. Sci Total Environ. 2014;470-471:58-75.
Mohapatra, D. P., Brar, S. K., Tyagi, R. D., Picard, P., & Surampalli, R. Y. (2014). Analysis and advanced oxidation treatment of a persistent pharmaceutical compound in wastewater and wastewater sludge-carbamazepine. The Science of the Total Environment, 470-471, 58-75. https://doi.org/10.1016/j.scitotenv.2013.09.034
Mohapatra DP, et al. Analysis and Advanced Oxidation Treatment of a Persistent Pharmaceutical Compound in Wastewater and Wastewater Sludge-carbamazepine. Sci Total Environ. 2014 Feb 1;470-471:58-75. PubMed PMID: 24140682.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Analysis and advanced oxidation treatment of a persistent pharmaceutical compound in wastewater and wastewater sludge-carbamazepine. AU - Mohapatra,D P, AU - Brar,S K, AU - Tyagi,R D, AU - Picard,P, AU - Surampalli,R Y, Y1 - 2013/10/16/ PY - 2013/04/03/received PY - 2013/09/12/revised PY - 2013/09/12/accepted PY - 2013/10/22/entrez PY - 2013/10/22/pubmed PY - 2014/8/15/medline KW - AOP KW - APCI KW - ASE KW - Advanced oxidation processes KW - CBZ KW - Carbamazepine KW - GC-MS KW - HPLC KW - II KW - LC-MS KW - LC-MS/MS KW - LDTD KW - LI KW - LLE KW - LOD KW - MAE KW - MEC KW - PNEC KW - PhACs KW - Quantification KW - Risk analysis KW - SE KW - SFE KW - SPE KW - Soxhlet extraction KW - UV KW - VAP KW - WW KW - WWS KW - WWTP KW - Wastewater KW - Wastewater sludge KW - accelerated solvent extraction KW - advanced oxidation process KW - atmospheric pressure chemical reactions KW - carbamazepine KW - gas chromatography–mass spectrometry KW - high performance liquid chromatography KW - irradiation intensity KW - laser diode thermal desorption KW - light intensity KW - limit of detection KW - liquid chromatography–mass spectrometry KW - liquid chromatography–mass spectrometry/mass spectrometry KW - liquid–liquid extraction KW - measured environmental concentration KW - microwave-assisted extraction KW - pharmaceutically active compounds KW - predicted no-effect environmental concentration KW - solid phase extraction KW - supercritical fluid extraction KW - ultra violet KW - value added products KW - wastewater KW - wastewater sludge KW - wastewater treatment plant SP - 58 EP - 75 JF - The Science of the total environment JO - Sci. Total Environ. VL - 470-471 N2 - Pharmaceutically active compounds (PhACs) are considered as emerging environmental problem due to their continuous input and persistence to the aquatic ecosystem even at low concentrations. Among them, carbamazepine (CBZ) has been detected at the highest frequency, which ends up in aquatic systems via wastewater treatment plants (WWTPs) among other sources. The identification and quantification of CBZ in wastewater (WW) and wastewater sludge (WWS) is of major interest to assess the toxicity of treated effluent discharged into the environment. Furthermore, WWS has been subjected for re-use either in agricultural application or for the production of value-added products through the route of bioconversion. However, this field application is disputable due to the presence of these organic compounds and in order to protect the ecosystem or end users, data concerning the concentration, fate, behavior as well as the perspective of simultaneous degradation of these compounds is urgently necessary. Many treatment technologies, including advanced oxidation processes (AOPs) have been developed in order to degrade CBZ in WW and WWS. AOPs are technologies based on the intermediacy of hydroxyl and other radicals to oxidize recalcitrant, toxic and non-biodegradable compounds to various by-products and eventually to inert end products. The purpose of this review is to provide information on persistent pharmaceutical compound, carbamazepine, its ecological effects and removal during various AOPs of WW and WWS. This review also reports the different analytical methods available for quantification of CBZ in different contaminated media including WW and WWS. SN - 1879-1026 UR - https://www.unboundmedicine.com/medline/citation/24140682/Analysis_and_advanced_oxidation_treatment_of_a_persistent_pharmaceutical_compound_in_wastewater_and_wastewater_sludge_carbamazepine_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0048-9697(13)01072-3 DB - PRIME DP - Unbound Medicine ER -